Active cytomegalovirus retinitis after the start of antiretroviral therapy

David Heiden; NiNi Tun; Frank N Smithuis; Jeremy David Keenan; Catherine E Oldenburg; Gary N Holland; W Lawrence Drew

doi:10.1136/bjophthalmol-2018-312406

Article info

Global issues

Active cytomegalovirus retinitis after the start of antiretroviral therapy

Authors

David Heiden Department of Ophthalmology, California Pacific Medical Center, Pacific Eye Associates, San Francisco, USA Center for Innovation in Eye Care, Seva Foundation, Berkeley, USA PubMed articles Google scholar articles
NiNi Tun Medical Action Myanmar, Yangon, Myanmar PubMed articles Google scholar articles
Frank N Smithuis Myanmar Oxford Clinical Research Unit and Medical Action Myanmar, Yangon, Myanmar PubMed articles Google scholar articles
Jeremy David Keenan Francis I. Proctor Foundation, University of California, San Francisco, San Francisco, USA PubMed articles Google scholar articles
Catherine E Oldenburg Francis I. Proctor Foundation, University of California, San Francisco, San Francisco, USA PubMed articles Google scholar articles
Gary N Holland Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, USA Ocular Inflammatory Disease Center, Jules Stein Eye Institute, Los Angeles, USA PubMed articles Google scholar articles
W Lawrence Drew Departments of Laboratory Medicine, UCSF and Mount Zion Medical Center, San Francisco, USA PubMed articles Google scholar articles

Correspondence to Dr David Heiden, California Pacific Medical Center Department of Ophthalmology, Pacific Eye Associates, San Francisco, USA; davidheiden{at}gmail.com

View Full Text

Citation

Heiden D, Tun N, Smithuis FN, et al

Active cytomegalovirus retinitis after the start of antiretroviral therapy

British Journal of Ophthalmology 2019;103:157-160.

Publication history

Received April 12, 2018
Revised August 14, 2018
Accepted August 16, 2018
First published September 8, 2018.

Online issue publication

January 22, 2019

Article Versions

Previous version (8 September 2018).
You are viewing the most recent version of this article.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password